About 300 reports

Executive Summary The Global Multiple Sclerosis Market is estimated at USD 26.01 Billion in the year 2020. The introduction of disease-modifying drugs as a treatment option is a key factor that drives the growth of the global multiple sclerosis market. Various technological advancements, such as the development of innovative...

  • Neurological Disorder
  • World
  • Health Expenditure
  • Drug Approval

Rare Neurological Disease Treatment market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Rare Neurological Disease Treatment Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Rare Neurological Disease Treatment...

  • Neurological Disorder
  • World

Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, and Other Rare Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global orphan drugs market was valued at $1,40,000.0 million in...

  • Therapy
  • Cancer
  • Neurological Disorder
  • World
  • APAC

Global Neurostimulation Devices Market to Reach $18,033.0 Million by 2030 Market Report Coverage - Neurostimulation Devices Market Segmentation • By Product Type: Implantable and non-implantable Implantable neurostimulation devices can be further segmented into seven types - spinal...

  • Neurological Disorder
  • World
  • Drug Approval
  • Disability-Adjusted Life Years

Rare Neurological Disease Treatment Market Report Overview Rare Neurological Disease Treatment market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Rare Neurological Disease Treatment market types and applications. It is a focused study...

  • Neurological Disorder
  • World
  • Health Provider Density

Abstract: - Global Therapeutic Plasma Exchange Market to Reach $1.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Therapeutic Plasma Exchange estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.9% over the analysis...

  • Neurological Disorder
  • World
  • China
  • United States
  • Europe
  • Japan
  • APAC
  • Canada

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass Research Platform - Complimentary...

  • Clinical Nutrition
  • Neurological Disorder
  • Chronic Disease
  • World
  • Chronic Disease Prevalence
  • Elderly Population

Abstract: - Global Medical Microbiology Testing Technologies Market to Reach $3.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Medical Microbiology Testing Technologies estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR...

  • Infectious Disease
  • Clinical Microbiology Testing
  • Respiratory Disease
  • Neurological Disorder
  • World
  • China
  • United States

Asia Pacific, the rare neurological disease treatment market, is anticipated to reach US$ 2,437.02 Mn in 2027 from US$ 1,225.38 Mn in 2019. The market is projected to grow with a CAGR of 9.2% from 2020-2027. The rare neurological disease treatment market is growing primarily due to the rising prevalence of rare neurological diseases,...

  • Neurological Disorder
  • APAC
  • Dementia Prevalence
  • Elderly Population

Europe, the rare neurological disease treatment market, is anticipated to reach US$ 3,763.41 Mn in 2027 from US$ 2,048.10 Mn in 2019. The market is projected to grow with a CAGR of 8.1% from 2020-2027. The rare neurological disease treatment market is growing primarily due to the rising prevalence of rare neurological diseases, increasing...

  • Neurological Disorder
  • Europe
  • Dementia Prevalence
  • Drug Approval

North America, the rare neurological disease treatment market, is anticipated to reach US$ 6,113.29 Mn in 2027 from US$ 3,184.10 Mn in 2019. The market is projected to grow with a CAGR of 8.7% from 2020-2027. The rare neurological disease treatment market is growing primarily due to the rising prevalence of rare neurological diseases,...

  • Neurological Disorder
  • North America
  • Drug Approval
  • Elderly Population

HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 Summary HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HIV Related Neurological Diseases pipeline landscape. The report provides comprehensive...

  • Neurological Disorder
  • Infectious Disease
  • World

Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body.Major causes of neurological disorders include brain, spinal cord, or nerve injury; genetic disorders; congenital abnormalities; infections; and lifestyle. Neurological diseases...

  • Neurological Disorder
  • Neurodegenerative Disease
  • World

The global rare neurological disease treatment market is expected to reach US$13,830.96 million by 2027 from US$ 7,300.12 million in 2019. The market is estimated to grow at a CAGR of 8.5% from 2020 to 2027. Driving factors of the rare neurological disease treatment market are growing prevalence of rare neurological diseases and favorable...

  • Neurological Disorder
  • APAC
  • World
  • North America
  • Drug Approval
  • Gross Domestic Product

The US therapeutic plasma exchange market is projected to reach USD 243 million by 2025 from USD 178 million in 2020, at a CAGR of 6.3% during the forecast period. Growth in this market is driven by the rising prevalence of chronic diseases and technological advancements. However, factors such as the high cost of apheresis devices and therapeutic...

  • Blood Supply
  • Therapy
  • Neurological Disorder
  • United States
  • Mortality Rate
  • Chronic Disease Prevalence

The blood brain barrier technologies market is expected to reach US$ 5,101.94 million by 2028 from US$ 1,041.05 million in 2021; it is estimated to register a CAGR of 25.5% from 2021 to 2028. Growing prevalence of neurological disorders, and increasing geriatric population and rising prevalence of age-associated neurological disorders are...

  • Mental Health
  • Neurological Disorder
  • Dementia
  • Psychotic Disorder
  • Pharmaceutical
  • Infectious Disease
  • Research And Development
  • World
  • APAC
  • Europe
  • Dementia Prevalence
  • Health Expenditure

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Neurological Disorder
  • World
  • Elderly Population
  • Cancer Incidence

Major players in the cranial implants market are B. Braun Melsungen AG, DePuy Synthes (Johnson and Johnson), Stryker Corporation, Zimmer Biomet, Kelyiniam Global Inc, Medartis AG, Osteomed, KLS Martin Group, Renishaw Plc, and Xilloc Medical B.V. The global cranial implants market is expected to grow from $0.91 billion in 2021 to $0.99...

  • Neurological Disorder
  • Medical Device
  • Psychotic Disorder
  • World
  • United States

Major players in the brain and neuroimaging devices market are GE, Siemens, Philips, Canon, Hitachi Medical Systems, Medtronic Plc, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co Ltd, and Elekta. The global brain and neuroimaging devices market is expected to grow from $33.17 billion in 2021 to $35.44 billion in 2022 at a compound...

  • Neurological Disorder
  • Diagnostic Imaging
  • World
  • Europe
  • North America
  • APAC
  • Diagnostic Imaging Density
  • Medical Technology Density

The North America neuromodulation market is projected to reach US$ 6,612.00 millionby2027 from US$3,029.72million in 2019; it is anticipated to grow at a CAGR of 10.6% from 2020 to 2027.Themarket growth is attributed to increasing incidence of neurological disorders and developments in neuromodulation technology across the region. Depression...

  • Neurological Disorder
  • Chronic Pain
  • Personality Disorder
  • Application
  • North America
  • United States
  • Drug Approval
  • Medical Devices Sales

Neuromodulation Market By Technology (Internal Neuromodulation, External Neuromodulation), By Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), By Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials),...

  • Biomaterial
  • Neurological Disorder
  • Neuromodulation Device
  • World
  • Hospital Number

Major players in the neurophysiology devices and equipment market are Medtronic Plc, Nihon Kohden Corporation, Dr. Langer Medical Gmbh, Natus Medical Incorporated, Inomed Medizintechnik, NuVasiveInc, Axon Healthcare Ltd., Bovie Medical Corporation, Neurosign, and Neurowave Systems. The global neurophysiology devices and equipment market...

  • Neurological Disorder
  • World
  • United States
  • APAC
  • Disability-Adjusted Life Years

The global neuroscience market reached a value of US$ 32.22 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 41.24 Billion by 2027 exhibiting a CAGR of 3.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Neurological Disorder
  • Healthcare
  • Magnetic Resonance Imaging
  • World
  • Health Expenditure
  • Mortality Rate

Neurological Disorder Drugs Market - Scope of the Report This report on the global neurological disorder drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027.The report provides...

  • Neurological Disorder
  • World

Major players in the cranial implants market are B. Braun Melsungen AG, DePuy Synthes (Johnson and Johnson), Stryker Corporation, Zimmer Biomet, Kelyiniam Global Inc, Medartis AG, Osteomed, KLS Martin Group, Renishaw Plc, Xilloc Medical B.V., Medtronic, Ortho Baltic, Evonos, and Synimed. The global cranial implants market is expected...

  • Neurological Disorder
  • Medical Device
  • Psychotic Disorder
  • World
  • United States
  • APAC

Major players in the neurophysiology devices and equipment market are Medtronic Plc, Nihon Kohden Corporation, Dr. Langer Medical Gmbh, Natus Medical Incorporated and Inomed Medizintechnik. The global neurophysiology devices and equipment market is expected to grow from $1.3 billion in 2020 to $1.4 billion in 2021 at a compound annual...

  • Neurological Disorder
  • Neurological Monitoring
  • World
  • United States
  • APAC
  • Disability-Adjusted Life Years

Report Scope: This report highlights the current and future market potential for electroceuticals.It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027. This...

  • Mental Health
  • Neurological Disorder
  • Medical Device
  • Cardiac Management
  • World

Major players in the brain and neuroimaging devices market are GE, Siemens, Philips, Canon, Hitachi Medical Systems, Medtronic Plc, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co., Ltd, and Elekta. The global brain and neuroimaging devices market is expected to grow from $31.429 billion in 2020 to $32.577 billion in 2021 at...

  • Neurological Disorder
  • Magnetic Resonance Imaging
  • World
  • Sweden
  • United Kingdom
  • Diagnostic Imaging Density
  • Medical Technology Density

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Neurological Disorder
  • World

The medical second opinion market was valued at US$ 3,204.57 million in 2019 and is projected to reach US$ 10,739.48 million by 2027; it is expected to grow at a CAGR of 16.32% during 2020-2028. The growth of the medical second opinion market is mainly attributed to the increasing prevalence of chronic diseases, growing emphasis on superior...

  • Healthcare
  • Health Insurance
  • Neurological Disorder
  • Transplantation
  • Blood Disease
  • Infectious Disease
  • World
  • APAC
  • Europe
  • Chronic Disease Prevalence
  • Cancer Incidence